Keywords: three-month, delay, prasugrel, nda, japanese, drugmaker, daiichi

Three-month delay for US prasugrel NDA

Article | 30 June 2008

Print This

Japanese drugmaker Daiichi Sankyo and US pharmaceutical major Eli Lilly say that the Food and Drug Administration has extended the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in